Diplomat Pharmacy, which operates the fourth largest specialty pharmacy in the US, raised $173 million by offering 13.3 million shares at $13, below the range of $14 to $16. Diplomat Pharmacy plans to list on the NYSE under the symbol DPLO. Credit Suisse, Morgan Stanley, J.P. Morgan and Wells Fargo Securities acted as lead managers on the deal.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
